Coastal Investment Advisors, Inc. Iovance Biotherapeutics, Inc. Transaction History

Coastal Investment Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$27.75 - $36.3 $863,441 - $1.13 Million	-31,115 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$27.21 - $41.0 $50,338 - $75,850	1,850 Added 6.32%	31,115 $854,000
Q1 2020 Apr 23, 2020	SELL	$19.54 - $38.85 $2,442 - $4,856	-125 Reduced 0.43%	29,265 $876,000
Q3 2019 Oct 18, 2019	BUY	$17.99 - $26.0 $14,661 - $21,190	815 Added 2.85%	29,390 $534,000
Q2 2019 Aug 01, 2019	BUY	$9.78 - $24.52 $103,032 - $258,318	10,535 Added 58.4%	28,575 $698,000
Q1 2019 May 15, 2019	BUY	$8.41 - $11.26 $151,716 - $203,130	18,040 New	18,040 $172,000

320

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.